Targeting Preclinical Diastolic Dysfunction to Prevent Heart Failure: Contemporary Insights View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-06-23

AUTHORS

Siu-Hin Wan, Horng H. Chen

ABSTRACT

Diastolic dysfunction encompasses both those who are asymptomatic and those who have heart failure symptoms. Preclinical diastolic dysfunction (PDD), defined as diastolic dysfunction with preserved ejection fraction (EF) without the presence of heart failure symptoms, is prevalent and may progress to heart failure with preserved EF (HFpEF). While the causative factors of HFpEF are multifactorial, targeting PDD and its associated comorbidities prior to development of symptoms can reduce development of heart failure. Diabetes, coronary artery disease, hypertension, and renal dysfunction are targets of treatment in those with diastolic dysfunction that may decrease the risk of heart failure development. This review will focus on PDD, its epidemiology, pathophysiology, comorbid conditions, and management that may prevent development of heart failure. More... »

PAGES

40

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12170-015-0466-1

DOI

http://dx.doi.org/10.1007/s12170-015-0466-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016019196


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA", 
            "Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wan", 
        "givenName": "Siu-Hin", 
        "id": "sg:person.01017265326.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017265326.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA", 
            "Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Horng H.", 
        "id": "sg:person.01024326700.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12020-012-9623-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015931238", 
          "https://doi.org/10.1007/s12020-012-9623-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00395-012-0308-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010474164", 
          "https://doi.org/10.1007/s00395-012-0308-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrcardio.2014.83", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014222378", 
          "https://doi.org/10.1038/nrcardio.2014.83"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-06-23", 
    "datePublishedReg": "2015-06-23", 
    "description": "Diastolic dysfunction encompasses both those who are asymptomatic and those who have heart failure symptoms. Preclinical diastolic dysfunction (PDD), defined as diastolic dysfunction with preserved ejection fraction (EF) without the presence of heart failure symptoms, is prevalent and may progress to heart failure with preserved EF (HFpEF). While the causative factors of HFpEF are multifactorial, targeting PDD and its associated comorbidities prior to development of symptoms can reduce development of heart failure. Diabetes, coronary artery disease, hypertension, and renal dysfunction are targets of treatment in those with diastolic dysfunction that may decrease the risk of heart failure development. This review will focus on PDD, its epidemiology, pathophysiology, comorbid conditions, and management that may prevent development of heart failure.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12170-015-0466-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1039476", 
        "issn": [
          "1932-9520", 
          "1932-9563"
        ], 
        "name": "Current Cardiovascular Risk Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "keywords": [
      "preclinical diastolic dysfunction", 
      "heart failure symptoms", 
      "diastolic dysfunction", 
      "heart failure", 
      "ejection fraction", 
      "failure symptoms", 
      "prevents heart failure", 
      "coronary artery disease", 
      "heart failure development", 
      "development of symptoms", 
      "target of treatment", 
      "renal dysfunction", 
      "artery disease", 
      "comorbid conditions", 
      "dysfunction", 
      "causative factors", 
      "symptoms", 
      "failure development", 
      "failure", 
      "HFpEF", 
      "hypertension", 
      "comorbidities", 
      "diabetes", 
      "pathophysiology", 
      "epidemiology", 
      "disease", 
      "treatment", 
      "risk", 
      "contemporary insights", 
      "review", 
      "development", 
      "management", 
      "factors", 
      "target", 
      "presence", 
      "fraction", 
      "conditions", 
      "insights", 
      "Targeting Preclinical Diastolic Dysfunction"
    ], 
    "name": "Targeting Preclinical Diastolic Dysfunction to Prevent Heart Failure: Contemporary Insights", 
    "pagination": "40", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016019196"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12170-015-0466-1"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12170-015-0466-1", 
      "https://app.dimensions.ai/details/publication/pub.1016019196"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_682.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12170-015-0466-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12170-015-0466-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12170-015-0466-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12170-015-0466-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12170-015-0466-1'


 

This table displays all metadata directly associated to this object as RDF triples.

117 TRIPLES      22 PREDICATES      67 URIs      56 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12170-015-0466-1 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author N25e9b2b14a484b228764a2d93ee06a8a
4 schema:citation sg:pub.10.1007/s00395-012-0308-y
5 sg:pub.10.1007/s12020-012-9623-1
6 sg:pub.10.1038/nrcardio.2014.83
7 schema:datePublished 2015-06-23
8 schema:datePublishedReg 2015-06-23
9 schema:description Diastolic dysfunction encompasses both those who are asymptomatic and those who have heart failure symptoms. Preclinical diastolic dysfunction (PDD), defined as diastolic dysfunction with preserved ejection fraction (EF) without the presence of heart failure symptoms, is prevalent and may progress to heart failure with preserved EF (HFpEF). While the causative factors of HFpEF are multifactorial, targeting PDD and its associated comorbidities prior to development of symptoms can reduce development of heart failure. Diabetes, coronary artery disease, hypertension, and renal dysfunction are targets of treatment in those with diastolic dysfunction that may decrease the risk of heart failure development. This review will focus on PDD, its epidemiology, pathophysiology, comorbid conditions, and management that may prevent development of heart failure.
10 schema:genre article
11 schema:inLanguage en
12 schema:isAccessibleForFree false
13 schema:isPartOf N5ce3b3cc9f0347819f85fdbe37a0a8d2
14 Na74779a2971144d088a2e78196a4b98d
15 sg:journal.1039476
16 schema:keywords HFpEF
17 Targeting Preclinical Diastolic Dysfunction
18 artery disease
19 causative factors
20 comorbid conditions
21 comorbidities
22 conditions
23 contemporary insights
24 coronary artery disease
25 development
26 development of symptoms
27 diabetes
28 diastolic dysfunction
29 disease
30 dysfunction
31 ejection fraction
32 epidemiology
33 factors
34 failure
35 failure development
36 failure symptoms
37 fraction
38 heart failure
39 heart failure development
40 heart failure symptoms
41 hypertension
42 insights
43 management
44 pathophysiology
45 preclinical diastolic dysfunction
46 presence
47 prevents heart failure
48 renal dysfunction
49 review
50 risk
51 symptoms
52 target
53 target of treatment
54 treatment
55 schema:name Targeting Preclinical Diastolic Dysfunction to Prevent Heart Failure: Contemporary Insights
56 schema:pagination 40
57 schema:productId N78045054597d4849bac39d89669ed20d
58 Ne81c899575454b36bc9088cb9282924e
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016019196
60 https://doi.org/10.1007/s12170-015-0466-1
61 schema:sdDatePublished 2022-01-01T18:39
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher N7d9e91f33df54c6ab69e9ce7c52437b3
64 schema:url https://doi.org/10.1007/s12170-015-0466-1
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N25e9b2b14a484b228764a2d93ee06a8a rdf:first sg:person.01017265326.77
69 rdf:rest N339b52dbe2b84bcd967f35849a84bc18
70 N339b52dbe2b84bcd967f35849a84bc18 rdf:first sg:person.01024326700.50
71 rdf:rest rdf:nil
72 N5ce3b3cc9f0347819f85fdbe37a0a8d2 schema:volumeNumber 9
73 rdf:type schema:PublicationVolume
74 N78045054597d4849bac39d89669ed20d schema:name dimensions_id
75 schema:value pub.1016019196
76 rdf:type schema:PropertyValue
77 N7d9e91f33df54c6ab69e9ce7c52437b3 schema:name Springer Nature - SN SciGraph project
78 rdf:type schema:Organization
79 Na74779a2971144d088a2e78196a4b98d schema:issueNumber 8
80 rdf:type schema:PublicationIssue
81 Ne81c899575454b36bc9088cb9282924e schema:name doi
82 schema:value 10.1007/s12170-015-0466-1
83 rdf:type schema:PropertyValue
84 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
85 schema:name Medical and Health Sciences
86 rdf:type schema:DefinedTerm
87 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
88 schema:name Cardiorespiratory Medicine and Haematology
89 rdf:type schema:DefinedTerm
90 sg:journal.1039476 schema:issn 1932-9520
91 1932-9563
92 schema:name Current Cardiovascular Risk Reports
93 schema:publisher Springer Nature
94 rdf:type schema:Periodical
95 sg:person.01017265326.77 schema:affiliation grid-institutes:grid.66875.3a
96 schema:familyName Wan
97 schema:givenName Siu-Hin
98 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017265326.77
99 rdf:type schema:Person
100 sg:person.01024326700.50 schema:affiliation grid-institutes:grid.66875.3a
101 schema:familyName Chen
102 schema:givenName Horng H.
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50
104 rdf:type schema:Person
105 sg:pub.10.1007/s00395-012-0308-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1010474164
106 https://doi.org/10.1007/s00395-012-0308-y
107 rdf:type schema:CreativeWork
108 sg:pub.10.1007/s12020-012-9623-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015931238
109 https://doi.org/10.1007/s12020-012-9623-1
110 rdf:type schema:CreativeWork
111 sg:pub.10.1038/nrcardio.2014.83 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014222378
112 https://doi.org/10.1038/nrcardio.2014.83
113 rdf:type schema:CreativeWork
114 grid-institutes:grid.66875.3a schema:alternateName Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA
115 schema:name Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA
116 Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA
117 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...